Chongqing Duoputai Pharmaceutical Technology

Chongqing Duoputai Pharmaceutical is a specialized Chinese pharmaceutical company focused on the research, development, and production of treatments for cardiovascular and cerebrovascular diseases. The company is most notable for its flagship product, Maixuekang, an antithrombotic medication derived from natural hirudin extracted from leeches. Duoputai integrates modern biotechnology with traditional medicinal knowledge to create high-purity natural products and chemical formulations. Their operations include a complete industrial chain from raw material cultivation to advanced manufacturing and clinical application. Headquartered in Chongqing, the company maintains a strong market position in China's domestic anticoagulant sector. Duoputai's research pipeline continues to explore microcirculation and vascular health through both innovative and modernized traditional therapies.